Connect with us

Legal & Regulation

New USDA Hemp Rule Proposal Gets Signature from Trump’s White House



  • The USDA has established interim rules, benefiting hemp farmers seeking to capitalize on the crop.
  • The FDA has stated that they are years away from establishing rules and that they are waiting on the approval of Congress.

Ever since the 2018 Farm Bill, the USDA has been making progress on the establishing of hemp regulation. According to a recent article from Marijuana Moment, a top official in the department confirmed this month that the new rules would be ready for release within a few weeks. Since that progress, a final review of the proposal has been approved by the White House Office of Management and Budget (OMB). Furthermore, the new interim rules for the crop, submitted by the USDA, have been approved. This progress was reported on by Politico as well.

The full plan has not been released, but it is expected that these details will offer more clarity on the policies regarding THC, like those on the THC potency testing and the standards being set forth for quality control. Public comment will be welcomed on these matters soon.

The regulations have been highly anticipated by hemp farmers, considering the promises made by USDA officials to issue them. Last week, a letter was sent to the USDA by Reps. Chellie Pingree (D-ME) and Jared Golden (D-ME), pushing for the department to abide by the obligations that the Farm Bill outlined to “expeditiously finalize the hemp rules.”

The pair stated,

“During these difficult economic times for farmers, hemp provides a promising market for farmers in Maine and across the country. We respectfully ask that you expedite the interim final rule on hemp so that this growing industry is not further stifled by regulatory uncertainty.”

Throughout this waiting period, the lawmakers have issued many other inquiries, hoping that the hemp industry gains further clarification.

There have been many steps that the USDA has taken to offer guidance to the hemp manufacturers in the industry during the creation of interim rules. One such step by the department has been on clarifying policies surrounding the correct way to both import and export hemp and its seeds. In August, the producers of hemp that were authorized under the 2014 Farm Bill would be eligible for federal crop insurance. The final rule approval will make it possible to expand this coverage.

Now, the Food and Drug Administration is still feeling the pressure for their own regulations on hemp-based CBD products. Senate Majority Leaders Mitch McConnell and Chuck Schumer have pushed for the FDA to create different rules that would allow food items and dietary supplements to be legally marketed. However, without congressional action, it could be years before the FDA can actually create these rules.

Luice resides in Pune, India and has recently taken up a kinship with freelance writing. For the past few years, he has been working at Springer Nature in the field of Nanobiotechnology. When not analyzing medical literature and scientific research data, Luice enjoys watching and playing football as well as going on a long hike.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.